Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignanciesZachary A. Hing, Rosa Lapalombella, Katie Williams et al.|Leukemia|2016Cited by 144
Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelinationJeffery D. Haines, Patrizia Casaccia, Olivier Herbin et al.|Nature Neuroscience|2015Cited by 97
Next Generation XPO1 Inhibitor Shows Improved Efficacy and In Vivo Tolerability in Hematologic MalignanciesZachary A. Hing, Rosa Lapalombella, Ho Yee Joyce Fung et al.|Blood|2015Cited by 1